[Bronchoplastic surgery for non small-cell lung cancer]

Area of Science:

• Thoracic Surgery
• Surgical Oncology

Context:

• Non-small cell lung cancer (NSCLC) treatment often involves standard lung resections.
• Bronchoplastic surgery presents an alternative or adjunct to standard procedures.
• Central tumor locations can pose challenges for traditional surgical approaches.

Purpose:

• To evaluate the post-operative morbidity and mortality associated with bronchoplastic surgery.
• To identify potential complications and risk factors specific to bronchoplastic resections.
• To determine the oncological radicality and long-term efficacy of bronchoplastic surgery compared to standard resections.

Summary:

• This study assessed the outcomes of 39 patients undergoing bronchoplastic surgery for non-small cell lung cancer.
• Results indicate very good immediate and long-term outcomes, comparable to standard lung resections.
• Bronchoplastic surgery is indicated for centrally located tumors, regardless of respiratory function parameters.

Impact:

• Bronchoplastic surgery expands treatment options for non-small cell lung cancer, particularly for central tumors.
• The procedure demonstrates oncological safety and comparable efficacy to standard lung resections.
• Understanding risk factors can help minimize complications and optimize patient selection for bronchoplastic surgery.